Clinical research on application of transluminal renal arterial catheter radiofrequency ablation for blood pressure reduction in patients with drug-resistant essential hypertensio
Not Applicable
- Conditions
- Essential hypertension
- Registration Number
- JPRN-UMIN000010008
- Lead Sponsor
- Department of Advanced Cardiovascular Therapeutics, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Renal anomaly or incompetency: Narrowing, previous renal angioplasty or stenting, or bifurcation. 2) Estimated glomerular filtration ratio less than 45mL/min. 3) Myocardial infarction, angina pectoris, or cerebrovascular disorder within recent 6 months. 4) Type 1 diabetes. 5) Secondary hypertension. 6) Prominent bleeding risk or coagulating disorder. 7) Diagnosed as any non-cardiovascular disease with less than 12 months more to live. 8) Current participants for any other clinical trial, excluding under extended observation period for evaluating approved drugs or materials. 9) Pregnancy. 10) Disqualified by any cardiologist for participating in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method